Environmental mycobacteria in northern Malawi: implications for the epidemiology of tuberculosis and leprosy

被引:59
作者
Fine, PEM
Floyd, S
Stanford, JL
Nkhosa, P
Kasunga, A
Chaguluka, S
Warndorff, DK
Jenkins, PA
Yates, M
Ponninghaus, JM
机构
[1] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
[2] UCL Royal Free & Univ Coll Med Sch, Windeyer Inst Med Sci, Dept Med Microbiol, London W1P 6DB, England
[3] Bryb Glas, Llangcitho SY25 6TR, Cardigan, Wales
[4] Karonga Prevent Study, Chilumba, Karonga Dist, Malawi
[5] Kings Coll Hosp Dulwich, Mycobacterial Reference Lab, London SE22 8QF, England
关键词
D O I
10.1017/S0950268801005532
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
More than 36000 individuals living in rural Malawi were skin tested with antigens derived from 12 different species of environmental mycobacteria. Most were simultaneously tested with RT23 tuberculin, and all were followed up for both tuberculosis and leprosy incidence. Skin test results indicated widespread sensitivity to the environmental antigens, in particular to Mycobacterium scrofulaceum, M. intracellulare and one strain of M. fortuitum. Individuals with evidence of exposure to 'fast growers' (i.e. with induration to antigens from fast growers which exceeded their sensitivity to tuberculin), but not those exposed to 'slow growers', were at reduced risk of contracting both tuberculosis and leprosy, compared to individuals whose indurations to the environmental antigen were less than that to tuberculin. This evidence for cross protection from natural exposure to certain environmental mycobacteria may explain geographic distributions of mycobacterial. disease and has important implications for the mechanisms and measurement of protection by mycobacterial. vaccines.
引用
收藏
页码:379 / 387
页数:9
相关论文
共 24 条
[1]   Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae [J].
AbouZeid, C ;
Gares, MP ;
Inwald, J ;
Janssen, R ;
Zhang, Y ;
Young, DB ;
Hetzel, C ;
Lamb, JR ;
Baldwin, SL ;
Orme, IM ;
Yeremeev, V ;
Nikonenko, BV ;
Apt, AS .
INFECTION AND IMMUNITY, 1997, 65 (05) :1856-1862
[2]  
BECHELLI LM, 1973, B WORLD HEALTH ORGAN, V48, P257
[3]  
EDWARDS LB, 1973, AM REV RESPIR DIS, V108, P1334
[4]  
EDWARDS LB, 1969, AM REV RESPIR DIS, V99, P1
[5]   DELAYED-TYPE HYPERSENSITIVITY, MYCOBACTERIAL VACCINES AND PROTECTIVE IMMUNITY [J].
FINE, PEM ;
STERNE, JAC ;
PONNIGHAUS, JM ;
REES, RJW .
LANCET, 1994, 344 (8932) :1245-1249
[6]   VARIATION IN PROTECTION BY BCG - IMPLICATIONS OF AND FOR HETEROLOGOUS IMMUNITY [J].
FINE, PEM .
LANCET, 1995, 346 (8986) :1339-1345
[7]  
Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962
[8]   PATTERNS OF INITIAL AND ACQUIRED ANTITUBERCULOSIS DRUG-RESISTANCE IN KARONGA DISTRICT, MALAWI [J].
GLYNN, JR ;
JENKINS, PA ;
FINE, PEM ;
PONNIGHAUS, JM ;
STERNE, JAC ;
MKANDWIRE, PK ;
NYASULU, S ;
BLISS, L ;
WARNDORFF, DK .
LANCET, 1995, 345 (8954) :907-910
[9]   THE EPIDEMIOLOGY OF DISSEMINATED NONTUBERCULOUS MYCOBACTERIAL INFECTION IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) [J].
HORSBURGH, CR ;
SELIK, RM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (01) :4-7
[10]  
MCINTYRE G, 1986, EUR J RESPIR DIS, V69, P146